"I wasn’t expecting these results among women in this lower age group, because we usually see increased risk for heart disease among older women," one cardiologist said. "It was definitely surprising.”

The long-term impact of moderate PPM remains unclear. To learn more, researchers explored dozens of different studies from over the years, sharing their work in the Journal of the American Heart Association.

Research published in 2018 caused many in the cardiology community to shy away from using these devices, and the FDA even issued warnings about their safety. However, new data suggest paclitaxel-coated balloons and stents are safe. 

"This finding suggests racial and gender bias as a potential contributor to the organ acceptance decision-making process," researchers wrote in JAMA.

The Embolize Trial will test multiple procedures and assess any reduction in pain scores and medication usage.

Only orthopedic surgeons and neurologists/psychiatrists received more industry payments from 2013 to 2022 than cardiologists. Also, the two prescription medications associated with the most physician payments were a blood thinner and an anticoagulant. 

Hoping to gain a better understanding of how TAVR may impact a patient’s long-term cardiovascular health, researchers explored data from more than 200,000 patients and shared their findings in JACC: Cardiovascular Interventions.

UHC has labeled an IR service docs have been delivering for 9 years as “unproven and not medically necessary due to insufficient evidence of efficacy."